Apyx Medical Corp Long-Term Debt, Maturity, Year Three
Apyx Medical Corp (APYX) had Long-Term Debt, Maturity, Year Three of $35.28 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2026-03-10
- 2025-12-31: Long-Term Debt, Maturity, Year Three $35.28M.
- 2025-09-30: Long-Term Debt, Maturity, Year Three $35.28M.
- 2025-06-30: Long-Term Debt, Maturity, Year Three $35.28M.
- 2025-03-31: Long-Term Debt, Maturity, Year Three $35.28M.
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2025-12-31 | $35.28M 10-K · filed 2026-03-10 |
| 2025-09-30 | $35.28M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $35.28M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $35.28M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.22M 10-K · filed 2025-03-13 |
| 2024-09-30 | $2.22M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $2.22M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.22M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $0.00 10-K · filed 2024-03-21 |
| 2023-06-30 | $3.33M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $3.33M 10-Q · filed 2023-05-11 |
| 2017-09-30 | $2.46M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $2.46M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $2.46M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $2.46M 10-K · filed 2017-03-10 |
| 2014-12-31 | $2.93M 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |